Literature DB >> 1057374

The problems of tissue oxygenation in diabetes mellitus. III. The "three-in-one concept" for the development of diabetic microangiopathy and a rational approach to its prophylaxis.

J Ditzel.   

Abstract

Evidence for a causative relationship between prolonged tissue hypoxia and diabetic retinopathy and glomerulosclerosis are presented. Based on the assumption that one of the most fundamental requirements for optimal cellular metabolism is a constant cellular oxygen tension, the "three-in-one concept" for the development of diabetic microangiopathy is formulated. The term "three-in-one" is employed because this concept partly or completely includes "the glycoprotein-", "the hypoxia-", and "the growth hormone hypothesis". Diabetics show evidence of variability in the tissue oxygen availability/demand ratio which is compensated by three self-regulating factors: 1) an increase in local flow, 2) an increase in red cell 2,3-DPG leading to a shift to the right of the oxyhaemoglobin dissociation curve, and 3) an increase in the oxygen-binding capacity or the haemoglobin concentration. The level of plasma inorganic phosphate (Pi) is of importance in maintaining high 2,3-DPG levels. However, since Pi fluctuates depending upon changes in the control of diabetes, the regulatory mechanism of the 2,3-DPG modulated unloading of oxygen from the erythrocytes often becomes insufficient, and therefore in poorly regulated diabetics with less than optimal 2,3-DPG levels, the main load of compensation against tissue hypoxia is placed on an adjustment in the microcirculation of the organ involved. However, in order for the microvascular dilatation to occur, the cells must experience a hypoxic stimulus. The summation of the infinite number of discrete and occasionally pronounced hypoxic injuries to the tissue cells in association with the adverse effect of local vasodilatation with increased plasma permeation through the vessel walls might over the years lead to diabetic microangiopathy. Based on this theory the high level of Pi in diabetes becomes of particular significance. Our experience with a high phosphate diabetes diet in the treatment of diabetics is presented. This dietary regimen leads to a significant increase in the oxygen release capacity of the erythrocytes, suggesting an improvement in tissue oxygenation, and may therefore become of value in the prophylaxis of diabetic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1057374

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  6 in total

Review 1.  Ocular oxygen measurement.

Authors:  I M Hogeboom van Buggenum; G L van der Heijde; G J Tangelder; J W Reichert-Thoen
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

2.  Assessment of oxygen saturation in retinal vessels of normal subjects and diabetic patients with and without retinopathy using Flow Oximetry System.

Authors:  Mohamed A Ibrahim; Rachel E Annam; Yasir J Sepah; Long Luu; Millena G Bittencourt; Hyun S Jang; Paul Lemaillet; Beatriz Munoz; Donald D Duncan; Sheila West; Quan Dong Nguyen; Jessica C Ramella-Roman
Journal:  Quant Imaging Med Surg       Date:  2015-02

3.  The Association Between Hemoglobin HbA1c with Serum Inorganic Phosphate in Children with Type 1 Diabetes.

Authors:  Setila Dalili; Shahin Koohmanaee; Seyyed Amir Reza Nemati; Seyyedeh Azade Hoseini Nouri; Afagh Hassanzadeh Rad; Wesam Kooti
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-29       Impact factor: 3.168

4.  Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects.

Authors:  J F Fitzgibbons; R D Koler; R T Jones
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

5.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.

Authors:  Jørn Ditzel; Hans Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2009-10-08       Impact factor: 3.168

6.  Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients.

Authors:  Samuele Ceruti; Bruno Minotti; Andrea Glotta; Maira Biggiogero; Giovanni Bona; Martino Marzano; Pietro Greco; Marco Spagnoletti; Christian Garzoni; Karim Bendjelid
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.